Apicore US LLC.

Please contact us by phone or email to discuss new business opportunities.

Product Search : FDP Form:   And/Or   Name/Keyword:
View all Products
Riociguat
Product FDP Form: Solid Oral
FDP Presentation: Tablet
Apicore API Status: R & D
Apicore API Market Status: Development
DMF Status: -
Therapeautic category: soluble guanylate cyclase (sGC) stimulator
Dosage Form: Tablet
Route: oral
RLD: Adempas
Strengths: 0.5MG, 1.5MG, 1MG, 2.5MG, 2MG
Indication: Treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH)
Go To Products